Post-protocol therapy and informative censoring in the CANDOR study

Tomer Meirson; Gal Markel; Vinay Prasad; Aaron M. Goodman; Ghulam Rehman Mohyuddin

doi:10.1016/S1470-2045(22)00075-4

Post-protocol therapy and informative censoring in the CANDOR study

Tomer Meirson
, Gal Markel
, Vinay Prasad
, Aaron M. Goodman
, Ghulam Rehman Mohyuddin

Clinical Microbiology and Immunology

Rabin Medical Center Israel
University of California at San Francisco
University of California at San Diego
University of Utah

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	e97
Journal	The Lancet Oncology
Volume	23
Issue number	3
DOIs	https://doi.org/10.1016/S1470-2045(22)00075-4
State	Published - Mar 2022

Access to Document

10.1016/S1470-2045(22)00075-4

Cite this

@article{3cc86a15aa464075baa69d14ec035131,

title = "Post-protocol therapy and informative censoring in the CANDOR study",

author = "Tomer Meirson and Gal Markel and Vinay Prasad and Goodman, \{Aaron M.\} and Mohyuddin, \{Ghulam Rehman\}",

year = "2022",

month = mar,

doi = "10.1016/S1470-2045(22)00075-4",

language = "אנגלית",

volume = "23",

pages = "e97",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "3",

}

TY - JOUR

T1 - Post-protocol therapy and informative censoring in the CANDOR study

AU - Meirson, Tomer

AU - Markel, Gal

AU - Prasad, Vinay

AU - Goodman, Aaron M.

AU - Mohyuddin, Ghulam Rehman

PY - 2022/3

Y1 - 2022/3

UR - https://www.scopus.com/pages/publications/85125335164

U2 - 10.1016/S1470-2045(22)00075-4

DO - 10.1016/S1470-2045(22)00075-4

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 35240098

AN - SCOPUS:85125335164

SN - 1470-2045

VL - 23

SP - e97

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 3

ER -

Post-protocol therapy and informative censoring in the CANDOR study

Access to Document

Other files and links

Cite this